Inventor
WANG HEXIANG
CN16 patents
⚠️ This page may combine multiple inventors who share the name “WANG HEXIANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BEIGENE LTD
12 patentsUS11202782B2Dec 21, 2021
Treatment cancers using a combination comprising PARP inhibitors
BEIGENE LTD9 citations85
US10112952B2Oct 30, 2018
Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors
BEIGENE LTD5 citations83
US9617273B2Apr 11, 2017
Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors
BEIGENE LTD6 citations83
US9393232B2Jul 19, 2016
Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones
BEIGENE LTD15 citations83
US10647714B2May 12, 2020
5 or 8-substituted imidazo[1,5-a]pyridines as indoleamine and/or tryptophane 2,3-dioxygenases
BEIGENE LTD2 citations73
US10280163B2May 7, 2019
5 or 8-substituted imidazo[1, 5-a] pyridines as indoleamine and/or tryptophane 2, 3-dioxygenases
BEIGENE LTD5 citations73
US10501467B2Dec 10, 2019
Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors
BEIGENE LTD2 citations72
US10457680B2Oct 29, 2019
Process for preparing a PARP inhibitor, crystalline forms, and uses thereof
BEIGENE LTD3 citations70
US11472788B2Oct 18, 2022
Benzoimidazoles as selective inhibitors of indoleamine 2,3-dioxygenases
BEIGENE LTD1 citations62
US10882856B2Jan 5, 2021
5 or 8-substituted imidazo [1,5-a] pyridines as selective inhibitors of indoleamine and/or tryptophane 2,3-dioxygenases
BEIGENE LTD1 citations62
US10899763B2Jan 26, 2021
Crystalline forms of salts of fused penta-cyclic dihydrodiazepinocarbazolones, and uses thereof
BEIGENE LTD1 citations58
US9827226B2Nov 28, 2017
Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones
BEIGENE LTD0 citations51